Zymeworks Bc Inc.

Oncothyreon Inc.

Diana F Hausman

Scott Peterson

Sandy Koppenol

Linda Pestano

Jeffrey Millard

Robert Kirkman

Nina E Weisser

Gerald J Rowse

Neil C Josephson

Rose Kamyee Lai

Patrick Kaminker

Described herein is a method of treating biliary tract cancer (BTC) comprising administering a bispecific antigen-binding construct targeting HER2 or a bispecific antigen-binding construct targeting HER2 linked to an auristatin analogue (ADC) to a subject.

Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancers

Described herein is a method of treating breast cancer comprising administering a bispecific antigen-binding construct targeting HER2 or a bispecific antigen-binding construct targeting HER2 linked to an auristatin analogue (ADC) in combination with a CDK4/6 inhibitor to a subject.

Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancer

Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.

MUC1 based glycolipopeptide vaccine with adjuvant

Growing community of inventors

Seattle, WA, United States of America

Diana F Hausman